Glucagon‐Like Peptide‐1 Receptor Agonists as Adjunctive Therapy for Hidradenitis Suppurativa in Patients With Overweight/Obesity: A Narrative Review of Efficacy, Safety, and Quality‐of‐Life Outcomes

Documenti analoghi

• The influence of social media on public attitudes and behaviors towards cosmetic dermatologic procedures and skin care practices: A study in Saudi Arabia
  di: Almuntsrbellah Almudimeegh, et al.
  Pubblicazione: (2024)
• Occipital Extracranial Dermoid Cyst in a Neonate With Cardiofaciocutaneous Syndrome Type 4 ( CFC4 ): A Case Report
  di: Mona Alkallabi, et al.
  Pubblicazione: (2026)
• Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Reduced Disease Severity and Pain in Hidradenitis Suppurativa: A Retrospective Study
  di: Zahidul Islam, et al.
  Pubblicazione: (2025)
• Extensive Type V Truncal Aplasia Cutis Congenita in a Surviving Twin With Fetus Papyraceus : A Case Report
  di: Assaf Ghallab Alharbi, et al.
  Pubblicazione: (2026)
• Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery
  di: Zayed Rashid, et al.
  Pubblicazione: (2025)